NVIDIA: pharmaceutical major Bristol Myers Squib…

From the Jul 21, 2026 daily brief

NVIDIA: pharmaceutical major Bristol Myers Squibb will build the life-science industry's "most advanced AI factory" on its next-generation Vera Rubin platform ("AI factory" is NVIDIA's marketing term for a full compute facility plus software stack) (NVIDIA, Jul 20). The signal is in the buyer's identity: a traditional big-pharma company putting its name behind NVIDIA's next-generation platform is one countable data point for "AI compute demand diffusing beyond the tech industry." But the signal's direction is unresolved: is this replacing an existing cloud or GPU supplier, or net-new incremental spend? The release doesn't say; neither scale nor dollars are disclosed. We log direction only.

More in this section

• Product & chips Sep 10, 2026 1 sources

  Customers of chip-design tool vendors have started capping tokens engineer by engineer — and a year ago nobody cared what that line cost.

  Product leaders from five electronic design automation and AI chip-design tool vendors sai…

• Product & chips Sep 10, 2026 1 sources

  The new flagship's enterprise edition went live with its first published prices, and its own account of the mechanism doubles as an audit cost.

  OpenAI's enterprise announcement on September 9 recast this model from "the smartest model…

• Product & chips Sep 9, 2026 1 sources

  OpenAI says its first in-house inference chip delivers 1.5 to 1.9 times the throughput per watt of "the commercial systems tested" — and does not say which systems those were.

  A document signed by CFO Sarah Friar gives the first numbers for Jalapeño, OpenAI's first …

• Product & chips Sep 9, 2026 1 sources

  Meta launched a personal AI agent called Muse, and the part worth recording is not what it does but that a payment network has written terms for a non-human buyer for the first time.

  Meta introduced Muse on September 8: it runs on a cloud virtual machine dedicated to each …